Immunological alterations induced by polyamine derivatives on murine splenocytes and human mononuclear cells

International Immunopharmacology

Volumn 4, Issue 4, 2004, Pages 547-556

  Cordeiro Da Silva, Anabela ^a,b   Tavares, Joana ^a,b   Araújo, Natália ^a,b   Cerqueira, Fátima ^a   Tomás, Ana ^a,b   Lin, Paul Kong Thoo ^c   Ouaissi, Ali ^d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Antiproliferative activity; Early activation marker; Polyamines derivatives; Th1 cytokines

Indexed keywords

BISNAPHTHALIMIDOPROPYLPUTRESCINE; CD69 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; POLYAMINE DERIVATIVE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; QUINOLONES; SPERMIDINE; SPLEEN; TIME FACTORS;

EID: 16544392791     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.02.009     Document Type: Article

References (14)

1. Tabor C.V., Tabor H. Polyamines. Annu. Rev. Biochem. 53:1984;749-790.
2. Thomas T., Thomas T.J. Polyamine metabolism and cancer. Cell. Mol. Life Sci. 58:2001;244-258.
3. Pegg A.E. Polyamine metabolism its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 48:1988;759-774.
4. Porter C.W., Sufrin J. Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res. 6:1986;525-542.
5. Casero R.A. Jr., Woster P.M. Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44:2001;1-26.
6. Eiseman J.L., Rogers F.A., Guo Y., Kaufmann J., Sentsz D.L., Klinger M.F.et al. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. Cancer Res. 58:1998;4864-4870.
7. Pavlov V., Kong Thoo Lin P., Rodilla V. Cytotoxicity, DNA binding and localisation of novel bis-naphthalimidopropyl polyamine derivatives. Chem.-Biol. Interact. 137:2001;15-24.
8. Bailly C., Brana M., Waring M.J. Sequence-selective intercalation of antitumour bis-naphthalimides into DNA. Evidence for an approach via the major groove. Eur. J. Biochem. 240:1996;195-208.
9. Pavlov V., Rodilla V., Kong Thoo Lin P. Cytotoxicity, DNA binding and localisation of novel bis-naphthalimidopropyl polyamine derivatives. Biotechnol. Biotechnol. 16:2002;118-123.
10. Pavlov V., Kong Thoo Lin P., Rodilla V. Growth, morphological and biochemical changes in oxa-spermine derivative-treated MCF-7 human breast cancer cells. Cell. Mol. Life Sci. 71:2002;1161-1173.
11. Kong Thoo Lin P., Dance A.M., Bestwick C., Milne L. The biological activities of new polyamine derivatives as potential therapeutic agents. Biochem. Soc. Trans. 31:2003;407-410.
12. Johnson R., Cubria J.C., Reguera R.M., Balana-Fouce R., Ordonez D. Interaction of cationic diamidines with Leishmania infantum DNA. Biol. Chem. 379:1998;925-930.
13. Testi R., Phillips J.H., Lanier L.L. T cell activation via Leu-23 (CD69). J. Immunol. 143:1989;1123-1128.
14. Hasko G., Kuhel D.G., Marton A., Nemeth Z.H., Deitch E.A., Szabo C. Spermine differentially regulates the production of interleukin-12 p40 and interleukin-10 and suppresses the release of the T helper 1 cytokine interferon-gamma. Shock. 14:2000;144-149.